BRIEF-Valeant Pharmaceuticals seeks to extend deadline for filing 10-K

Wed Mar 30, 2016 7:25am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

March 30 (Reuters) - Valeant Pharmaceuticals International Inc

* Launches credit facility amendment

* Intends to file 10-K on or before April 29, 2016 , as previously disclosed

* Seeking to extend deadline for filing its form 10-K to May 31, 2016

* Extensions provide relief under credit facility in event form 10-K is not filed by April 29, 2016

* To extend deadline for filing its form 10-Q for quarter ending March 31, 2016 to July 31, 2016

* Also asking lenders to amend, among other things, interest coverage maintenance covenant and certain financial definitions

* "Is comfortable with its current liquidity position and cash flow generation for rest of year"

* Proposed waiver would also waive cross-default to indentures that arose when form 10-K not filed on March 15   Continued...